IL143351A0 - Human hybrid host cell for mammalian gene expression - Google Patents

Human hybrid host cell for mammalian gene expression

Info

Publication number
IL143351A0
IL143351A0 IL14335199A IL14335199A IL143351A0 IL 143351 A0 IL143351 A0 IL 143351A0 IL 14335199 A IL14335199 A IL 14335199A IL 14335199 A IL14335199 A IL 14335199A IL 143351 A0 IL143351 A0 IL 143351A0
Authority
IL
Israel
Prior art keywords
cells
human
recombinant
gene expression
mammalian gene
Prior art date
Application number
IL14335199A
Other languages
English (en)
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of IL143351A0 publication Critical patent/IL143351A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/02—Preparation of hybrid cells by fusion of two or more cells, e.g. protoplast fusion
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • C12N5/163—Animal cells one of the fusion partners being a B or a T lymphocyte
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
IL14335199A 1998-12-10 1999-12-08 Human hybrid host cell for mammalian gene expression IL143351A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/209,920 US6136599A (en) 1998-12-10 1998-12-10 Human hybrid host cell for mammalian gene expression
PCT/US1999/029332 WO2000034462A1 (en) 1998-12-10 1999-12-08 Human hybrid host cell for mammalian gene expression

Publications (1)

Publication Number Publication Date
IL143351A0 true IL143351A0 (en) 2002-04-21

Family

ID=22780882

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14335199A IL143351A0 (en) 1998-12-10 1999-12-08 Human hybrid host cell for mammalian gene expression
IL143351A IL143351A (en) 1998-12-10 2001-05-24 Human hybrid host cell for mammalian gene expression

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL143351A IL143351A (en) 1998-12-10 2001-05-24 Human hybrid host cell for mammalian gene expression

Country Status (27)

Country Link
US (1) US6136599A (sl)
EP (1) EP1137768B1 (sl)
JP (3) JP4332300B2 (sl)
KR (1) KR100627753B1 (sl)
CN (1) CN1230532C (sl)
AT (1) ATE306547T1 (sl)
AU (1) AU757188B2 (sl)
BG (1) BG65263B1 (sl)
BR (1) BRPI9916095B8 (sl)
CA (1) CA2353698C (sl)
CU (2) CU23382A3 (sl)
CZ (1) CZ302677B6 (sl)
DE (1) DE69927707T2 (sl)
DK (1) DK1137768T3 (sl)
ES (1) ES2249929T3 (sl)
HU (1) HU229775B1 (sl)
ID (1) ID30448A (sl)
IL (2) IL143351A0 (sl)
NO (1) NO330548B1 (sl)
PL (1) PL205549B1 (sl)
RO (1) RO121563B1 (sl)
RU (1) RU2228355C2 (sl)
SI (1) SI20693B (sl)
SK (1) SK287888B6 (sl)
TR (1) TR200101642T2 (sl)
UA (1) UA77642C2 (sl)
WO (1) WO2000034462A1 (sl)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6358703B1 (en) 1998-12-10 2002-03-19 Bayer Corporation Expression system for factor VIII
US6136599A (en) * 1998-12-10 2000-10-24 Bayer Corporation Human hybrid host cell for mammalian gene expression
US6348192B1 (en) * 1999-05-11 2002-02-19 Bayer Corporation Interleukin-2 mutein expressed from mammalian cells
US20040235715A1 (en) * 1999-11-12 2004-11-25 Bayer Corporation Method of producing glycosylated bikunin
US6569657B1 (en) * 2000-06-27 2003-05-27 Millennium Pharmaceuticals, Inc. 32140, a novel human aldehyde dehydrogenase and uses therefor
US7094587B2 (en) * 2000-06-27 2006-08-22 Millennium Pharmaceuticals, Inc. 16002 Molecules and uses therefor
US7723102B2 (en) * 2000-09-28 2010-05-25 Bayer Corporation Enhanced transfection system
MY139948A (en) * 2000-09-28 2009-11-30 Bayer Corp Enhanced transfection system
US20060073141A1 (en) * 2001-06-28 2006-04-06 Domantis Limited Compositions and methods for treating inflammatory disorders
KR100496861B1 (ko) 2002-09-26 2005-06-22 삼성전자주식회사 하나의 핸들러에 2개 이상의 테스트 보드를 갖는 테스트장비 및 그 테스트 방법
WO2004050683A2 (en) 2002-12-02 2004-06-17 Abgenix, Inc. Antibodies directed to tumor necrosis factor and uses thereof
US7244616B2 (en) 2003-06-27 2007-07-17 Bayer Pharmaceuticals Corporation Use of molecular chaperones for the enhanced production of secreted, recombinant proteins in mammalian cells
WO2006053299A2 (en) 2004-11-12 2006-05-18 Bayer Healthcare Llc Site-directed modification of fviii
NZ580530A (en) 2007-06-06 2012-04-27 Domantis Ltd Anti vegf polypeptides, antibody variable domains and antagonists
WO2009126564A1 (en) 2008-04-07 2009-10-15 Bayer Healthcare Llc Methods of recombinant production of glycoproteins
KR101005967B1 (ko) * 2008-04-12 2011-01-05 (주)셀트리온 우수한 재조합 단백질을 생산하기 위한 인간 숙주 세포
US9090948B2 (en) 2008-09-30 2015-07-28 Abbott Molecular Inc. Primers and probes for detecting human papillomavirus and human beta globin sequences in test samples
MY155287A (en) * 2009-06-10 2015-09-30 B T S Res Internat Pty Ltd Methods of generating hybrid/chimeric cells, and uses thereof
US11401514B2 (en) 2016-07-19 2022-08-02 Brandeis University Compositions and methods for identifying RNA binding polypeptide targets
EP3793596A1 (en) 2018-05-16 2021-03-24 MorphoSys AG Antibodies targeting glycoprotein vi
JP2022524449A (ja) 2019-03-14 2022-05-02 モルフォシス・アーゲー Ｃ５ａＲを標的とする抗体
EP4217391A1 (en) 2020-09-24 2023-08-02 MorphoSys AG Novel human antibodies binding to human cd3 epsilon
CN113604425B (zh) * 2021-06-22 2022-10-18 中山康天晟合生物技术有限公司 一种适应无血清培养基环境的wayne293 lvpro细胞及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6045849B2 (ja) * 1980-08-25 1985-10-12 林原 健 ヒトエリトロポエチンの製造方法
US6136599A (en) * 1998-12-10 2000-10-24 Bayer Corporation Human hybrid host cell for mammalian gene expression

Also Published As

Publication number Publication date
RU2228355C2 (ru) 2004-05-10
CZ302677B6 (cs) 2011-08-31
SK287888B6 (sk) 2012-03-02
AU757188B2 (en) 2003-02-06
AU1938300A (en) 2000-06-26
SI20693B (sl) 2008-12-31
JP5826311B2 (ja) 2015-12-02
BR9916095A (pt) 2001-09-04
UA77642C2 (en) 2007-01-15
RO121563B1 (ro) 2007-11-30
DK1137768T3 (da) 2005-12-19
DE69927707D1 (de) 2006-02-23
CA2353698A1 (en) 2000-06-15
DE69927707T2 (de) 2006-07-13
CU23238A1 (es) 2007-09-26
EP1137768A1 (en) 2001-10-04
EP1137768B1 (en) 2005-10-12
WO2000034462A1 (en) 2000-06-15
JP2002531125A (ja) 2002-09-24
HU229775B1 (en) 2014-07-28
TR200101642T2 (tr) 2001-11-21
KR20020002360A (ko) 2002-01-09
SK7912001A3 (en) 2002-03-05
HUP0104681A2 (hu) 2002-04-29
US6136599A (en) 2000-10-24
PL205549B1 (pl) 2010-04-30
NO330548B1 (no) 2011-05-16
SI20693A (sl) 2002-04-30
ATE306547T1 (de) 2005-10-15
BG105566A (en) 2002-03-29
IL143351A (en) 2009-12-24
HUP0104681A3 (en) 2005-10-28
NO20012806D0 (no) 2001-06-07
JP2014131513A (ja) 2014-07-17
KR100627753B1 (ko) 2006-09-26
CN1230532C (zh) 2005-12-07
BRPI9916095B8 (pt) 2021-05-25
JP4332300B2 (ja) 2009-09-16
JP5508740B2 (ja) 2014-06-04
CU23382A3 (es) 2009-06-25
BRPI9916095B1 (pt) 2015-10-13
CZ20012023A3 (cs) 2001-10-17
BG65263B1 (bg) 2007-10-31
EP1137768A4 (en) 2002-09-18
ID30448A (id) 2001-12-06
NO20012806L (no) 2001-06-07
JP2009148295A (ja) 2009-07-09
CN1339063A (zh) 2002-03-06
ES2249929T3 (es) 2006-04-01
CA2353698C (en) 2012-02-21

Similar Documents

Publication Publication Date Title
IL143351A0 (en) Human hybrid host cell for mammalian gene expression
Manuri et al. piggyBac transposon/transposase system to generate CD19-specific T cells for the treatment of B-lineage malignancies
Tjian et al. Biological activity of purified simian virus 40 T antigen proteins.
PT789766E (pt) Particulas quimericas do tipo papilomavirus
KR20120038531A (ko) 연속 세포 배양에서 목적 폴리펩티드 또는 바이러스를 생산하는 방법
AU2126688A (en) Serum free media for the growth of insect cells and expression of products thereby
JPH04228066A (ja) 外来遺伝子発現用培養細胞
CN102325881B (zh) 用于用动物细胞大量生产源自外源基因的蛋白质的表达载体及其应用
NZ512235A (en) Human hybrid host cell for mammalian gene expression
AU7710996A (en) Regulated protein expression in stably transfected mammalian cells
EP0235113A2 (en) Immortalization of primary cells
Graessmann et al. Fused cells are suited for microinjection
JP2500384B2 (ja) 生理活性物質の製造法
Stein et al. Acidic nuclear protein synthesis in Rous sarcoma virus infected chick embryo fibroblasts
Waldman et al. Transfer of herpes simplex virus thymidine kinase synthesized in bacteria by a high-expression plasmid to tissue culture cells by protoplast fusion
Bayley et al. Immortalization of rat keratinocytes by transfection with polyomavirus large T gene
AU666800B2 (en) Process for producing exogenous protein
JPH0732705B2 (ja) 動物細胞増殖用組成物およびそれを用いる動物細胞の増殖方法
Al et al. Optimization of Human Antibody Production by Xenohybridization of EBV-Transformed Cell Lines
Colman Microinjection and organelle transplantation techniques: Methods and applications: edited by JE Celis, A. Graessmann and A. Loyter, Academic Press, 1986.£ 47/$75.50 (hbk)£ 23/$36.95 (pbk)(xi+ 379 pages) ISBN 0 12 164722 6
Hacker Recombinant Protein Expression in Mammalian Cells